176P Real-world tumour response of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US clinical practices von Brufsky, A., Liu, X., Li, B., McRoy, L., Layman, R.M.

Volltext

329P - Comparative effectiveness of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US real-world clinical practices von Layman, R.M., Liu, X., Mardekian, J., McRoy, L.

Volltext

Comparative effectiveness of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US real-world clinical practices von Layman, R.M., Liu, X., Mardekian, J., McRoy, L.

Volltext

169P Overall survival with first-line palbociclib plus an aromatase inhibitor (AI) vs AI in metastatic breast cancer: A large real-world database analysis von Rugo, H.S., Brufsky, A., Liu, X., Li, B., McRoy, L., Chen, C., Layman, R.M., Cristofanilli, M., Torres, M.A., Curigliano, G., Finn, R.S., Demichele, A.

Volltext

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy von Du, L., Yau, C., Brown-Swigart, L., Gould, R., Krings, G., Hirst, G.L., Bedrosian, I., Layman, R.M., Carter, J.M., Klein, M., Venters, S., Shad, S., van der Noordaa, M., Chien, A.J., Haddad, T., Isaacs, C., Pusztai, L., Albain, K., Nanda, R., Tripathy, D., Liu, M.C., Boughey, J., Schwab, R., Hylton, N., DeMichele, A., Perlmutter, J., Yee, D., Berry, D., van't Veer, L., Valero, V., Esserman, L.J., Symmans, W.F.

Volltext

239P Efficacy of single-agent chemotherapy in endocrine therapy-refractory metastatic invasive lobular carcinoma von Mouabbi, J., Qiao, W., Raghavendra, A. Singareeka, Shen, Y., Tripathy, D., Layman, R.M.

Volltext

223P Real-world effectiveness of palbociclib (Pal) plus an aromatase inhibitor (AI) vs AI alone in patients who have metastatic breast cancer (mBC) with lung or liver metastases von Brufsky, A., Liu, X., Li, B., McRoy, L., Chen, C., Layman, R.M., Rugo, H.S.

Volltext

Real-world treatment patterns and outcomes of palbociclib in combination with an aromatase inhibitor in the US older patients with metastatic breast cancer von Rugo, H.S., Liu, X., Li, B., McRoy, L., Layman, R.M., Brufsky, A.

Volltext

SIOG2021-0022 - Real-world treatment patterns and outcomes of palbociclib in combination with an aromatase inhibitor in the US older patients with metastatic breast cancer von Rugo, H.S., Liu, X., Li, B., McRoy, L., Layman, R.M., Brufsky, A.

Volltext

204P Phase Ib study of gedatolisib plus palbociclib and endocrine therapy in women with hormone receptor positive advanced breast cancer: Updated results in treatment naïve patient... von Rugo, H.S., Wesolowski, R., Stringer-Reasor, E., Han, H., Specht, J., Dees, C., Kabos, P., Vaishampayan, U.N., Wander, S.A., Lu, J., Gogineni, K., Spira, A., Schott, A., Abu-Khalaf, M., Mutka, S., Suzuki, S., Gorbatchevsky, I., Layman, R.M.

Volltext